Patent details
EP4142770
Title:
SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
Basic Information
- Publication number:
- EP4142770
- PCT Application Number:
- EP2021060827
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217210921
- PCT Publication Number:
- WO2021219543
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
- French Title of Invention:
- SEMAGLUTIDE POUR LE TRAITEMENT DE LA STÉATOHÉPATITE NON ALCOOLIQUE
- German Title of Invention:
- SEMAGLUTID ZUR BEHANDLUNG DER NICHTALKOHOLISCHE STRATOHEPATITIS
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 01/04/2026
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 10/04/2026
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 11/03/2026
- Unitary Effect Registration Date:
- 10/04/2026
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 26/04/2021
- Grant date:
- 11/03/2026
- EP Publication Date:
- 08/03/2023
- PCT Publication Date:
- 04/11/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/03/2026
- EP B1 Publication Date:
- 11/03/2026
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/04/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/03/2026
-
-
- Name:
- Novo Nordisk A/S
- Address:
- Novo Allé, 2880 Bagsværd, Denmark (DK)
Inventor
1
- Name:
- TORSTENSON, Carl Richard
- Address:
- Denmark (DK)
2
- Name:
- PALLE, Mads, Sundby
- Address:
- Denmark (DK)
3
- Name:
- HANSEN, Morten
- Address:
- Denmark (DK)
4
- Name:
- DAMGAARD, Lars, Holm
- Address:
- Denmark (DK)
5
- Name:
- LINDER, Martin
- Address:
- Denmark (DK)
Priority
1
- Priority Number:
- 20171536
- Priority Date:
- 27/04/2020
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 20173341
- Priority Date:
- 06/05/2020
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
-
A61K 38/26;
A61P 1/16;
Publication
European Patent Bulletin
1
- Issue number:
- 202611
- Publication date:
- 11/03/2026
- Description:
- Grant (B1)
2
- Issue number:
- 202619
- Publication date:
- 06/05/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202620
- Publication date:
- 13/05/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |